Peptide Therapeutics Market Report by Type (Innovative, Generic), Type of Manufacturer (Outsourced, In-House), Synthesis Technology (Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis, Hybrid Technology), Routes of Administration (Parenteral, Oral, and Others), Application (Gastrointestinal Disorders, Neurological Disorders, Metabolic Disorders, Cancer, and Others), and Region 2025-2033

Peptide Therapeutics Market Report by Type (Innovative, Generic), Type of Manufacturer (Outsourced, In-House), Synthesis Technology (Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis, Hybrid Technology), Routes of Administration (Parenteral, Oral, and Others), Application (Gastrointestinal Disorders, Neurological Disorders, Metabolic Disorders, Cancer, and Others), and Region 2025-2033

Report Format: PDF+Excel | Report ID: SR112025A4510

1   Preface
2   Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction

    4.1    Overview
    4.2    Key Industry Trends
5   Global Peptide Therapeutics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Type
    6.1    Innovative
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Generic
        6.2.1 Market Trends
        6.2.2 Market Forecast
7   Market Breakup by Type of Manufacturer
    7.1    Outsourced
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    In-house
        7.2.1 Market Trends
        7.2.2 Market Forecast
8   Market Breakup by Synthesis Technology
    8.1    Solid Phase Peptide Synthesis
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Liquid Phase Peptide Synthesis
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Hybrid Technology
        8.3.1 Market Trends
        8.3.2 Market Forecast
9   Market Breakup by Routes of Administration
    9.1    Parenteral
        9.1.1 Market Trends
        9.1.2 Market Forecast
    9.2    Oral
        9.2.1 Market Trends
        9.2.2 Market Forecast
    9.3    Others
        9.3.1 Market Trends
        9.3.2 Market Forecast
10  Market Breakup by Application
    10.1    Gastrointestinal Disorders
        10.1.1 Market Trends
        10.1.2 Market Forecast
    10.2    Neurological Disorders
        10.2.1 Market Trends
        10.2.2 Market Forecast
    10.3    Metabolic Disorders
        10.3.1 Market Trends
        10.3.2 Market Forecast
    10.4    Cancer
        10.4.1 Market Trends
        10.4.2 Market Forecast
    10.5    Others
        10.5.1 Market Trends
        10.5.2 Market Forecast
11  Market Breakup by Region
    11.1    North America
        11.1.1 United States
           11.1.1.1 Market Trends
           11.1.1.2 Market Forecast
        11.1.2 Canada
           11.1.2.1 Market Trends
           11.1.2.2 Market Forecast
    11.2    Asia-Pacific
        11.2.1 China
           11.2.1.1 Market Trends
           11.2.1.2 Market Forecast
        11.2.2 Japan
           11.2.2.1 Market Trends
           11.2.2.2 Market Forecast
        11.2.3 India
           11.2.3.1 Market Trends
           11.2.3.2 Market Forecast
        11.2.4 South Korea
           11.2.4.1 Market Trends
           11.2.4.2 Market Forecast
        11.2.5 Australia
           11.2.5.1 Market Trends
           11.2.5.2 Market Forecast
        11.2.6 Indonesia
           11.2.6.1 Market Trends
           11.2.6.2 Market Forecast
        11.2.7 Others
           11.2.7.1 Market Trends
           11.2.7.2 Market Forecast
    11.3    Europe
        11.3.1 Germany
           11.3.1.1 Market Trends
           11.3.1.2 Market Forecast
        11.3.2 France
           11.3.2.1 Market Trends
           11.3.2.2 Market Forecast
        11.3.3 United Kingdom
           11.3.3.1 Market Trends
           11.3.3.2 Market Forecast
        11.3.4 Italy
           11.3.4.1 Market Trends
           11.3.4.2 Market Forecast
        11.3.5 Spain
           11.3.5.1 Market Trends
           11.3.5.2 Market Forecast
        11.3.6 Russia
           11.3.6.1 Market Trends
           11.3.6.2 Market Forecast
        11.3.7 Others
           11.3.7.1 Market Trends
           11.3.7.2 Market Forecast
    11.4    Latin America
        11.4.1 Brazil
           11.4.1.1 Market Trends
           11.4.1.2 Market Forecast
        11.4.2 Mexico
           11.4.2.1 Market Trends
           11.4.2.2 Market Forecast
        11.4.3 Others
           11.4.3.1 Market Trends
           11.4.3.2 Market Forecast
    11.5    Middle East and Africa
        11.5.1 Market Trends
        11.5.2 Market Breakup by Country
        11.5.3 Market Forecast
12  SWOT Analysis
    12.1    Overview
    12.2    Strengths
    12.3    Weaknesses
    12.4    Opportunities
    12.5    Threats
13  Value Chain Analysis
14  Porters Five Forces Analysis

    14.1    Overview
    14.2    Bargaining Power of Buyers
    14.3    Bargaining Power of Suppliers
    14.4    Degree of Competition
    14.5    Threat of New Entrants
    14.6    Threat of Substitutes
15  Price Analysis
16  Competitive Landscape

    16.1    Market Structure
    16.2    Key Players
    16.3    Profiles of Key Players
        16.3.1    Amgen Inc.
           16.3.1.1 Company Overview
           16.3.1.2 Product Portfolio
           16.3.1.3 Financials
           16.3.1.4 SWOT Analysis
        16.3.2    Apitope International NV
           16.3.2.1 Company Overview
           16.3.2.2 Product Portfolio
        16.3.3    Arch Biopartners Inc.
           16.3.3.1 Company Overview
           16.3.3.2 Product Portfolio
           16.3.3.3 Financials
        16.3.4    AstraZeneca plc
           16.3.4.1 Company Overview
           16.3.4.2 Product Portfolio
           16.3.4.3 Financials
           16.3.4.4 SWOT Analysis
        16.3.5    Circle Pharma Inc.
           16.3.5.1 Company Overview
           16.3.5.2 Product Portfolio
        16.3.6    Corden Pharma GmbH
           16.3.6.1 Company Overview
           16.3.6.2 Product Portfolio
        16.3.7    F. Hoffmann-La Roche AG
           16.3.7.1 Company Overview
           16.3.7.2 Product Portfolio
           16.3.7.3 SWOT Analysis
        16.3.8    Ipsen Group
           16.3.8.1 Company Overview
           16.3.8.2 Product Portfolio
           16.3.8.3 Financials
           16.3.8.4 SWOT Analysis
        16.3.9    Lonza Group AG
           16.3.9.1 Company Overview
           16.3.9.2 Product Portfolio
           16.3.9.3 Financials
           16.3.9.4 SWOT Analysis
        16.3.10    Novo Nordisk A/S
           16.3.10.1 Company Overview
           16.3.10.2 Product Portfolio
           16.3.10.3 Financials
           16.3.10.4 SWOT Analysis
        16.3.11    Pfizer Inc.
           16.3.11.1 Company Overview
           16.3.11.2 Product Portfolio
           16.3.11.3 Financials
           16.3.11.4 SWOT Analysis
        16.3.12    Teva Pharmaceuticals Industries Ltd.
           16.3.12.1 Company Overview
           16.3.12.2 Product Portfolio
           16.3.12.3 Financials
           16.3.12.4 SWOT Analysis
        16.3.13    Zealand Pharma A/S
           16.3.13.1 Company Overview
           16.3.13.2 Product Portfolio
           16.3.13.3 Financials

List of Figures

​Figure 1: Global: Peptide Therapeutics Market: Major Drivers and Challenges
Figure 2: Global: Peptide Therapeutics Market: Sales Value (in Billion USD), 2019-2024
Figure 3: Global: Peptide Therapeutics Market Forecast: Sales Value (in Billion USD), 2025-2033
Figure 4: Global: Peptide Therapeutics Market: Breakup by Type (in %), 2024
Figure 5: Global: Peptide Therapeutics Market: Breakup by Type of Manufacturer (in %), 2024
Figure 6: Global: Peptide Therapeutics Market: Breakup by Synthesis Technology (in %), 2024
Figure 7: Global: Peptide Therapeutics Market: Breakup by Routes of Administration (in %), 2024
Figure 8: Global: Peptide Therapeutics Market: Breakup by Application (in %), 2024
Figure 9: Global: Peptide Therapeutics Market: Breakup by Region (in %), 2024
Figure 10: Global: Peptide Therapeutics (Innovative) Market: Sales Value (in Million USD), 2019 & 2024
Figure 11: Global: Peptide Therapeutics (Innovative) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 12: Global: Peptide Therapeutics (Generic) Market: Sales Value (in Million USD), 2019 & 2024
Figure 13: Global: Peptide Therapeutics (Generic) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 14: Global: Peptide Therapeutics (Outsourced) Market: Sales Value (in Million USD), 2019 & 2024
Figure 15: Global: Peptide Therapeutics (Outsourced) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 16: Global: Peptide Therapeutics (In-house) Market: Sales Value (in Million USD), 2019 & 2024
Figure 17: Global: Peptide Therapeutics (In-house) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 18: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 19: Global: Peptide Therapeutics (Solid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 20: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market: Sales Value (in Million USD), 2019 & 2024
Figure 21: Global: Peptide Therapeutics (Liquid Phase Peptide Synthesis) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 22: Global: Peptide Therapeutics (Hybrid Technology) Market: Sales Value (in Million USD), 2019 & 2024
Figure 23: Global: Peptide Therapeutics (Hybrid Technology) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 24: Global: Peptide Therapeutics (Parenteral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 25: Global: Peptide Therapeutics (Parenteral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 26: Global: Peptide Therapeutics (Oral) Market: Sales Value (in Million USD), 2019 & 2024
Figure 27: Global: Peptide Therapeutics (Oral) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 28: Global: Peptide Therapeutics (Other Routes of Administration) Market: Sales Value (in Million USD), 2019 & 2024
Figure 29: Global: Peptide Therapeutics (Other Routes of Administration) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 30: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 31: Global: Peptide Therapeutics (Gastrointestinal Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 32: Global: Peptide Therapeutics (Neurological Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 33: Global: Peptide Therapeutics (Neurological Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 34: Global: Peptide Therapeutics (Metabolic Disorders) Market: Sales Value (in Million USD), 2019 & 2024
Figure 35: Global: Peptide Therapeutics (Metabolic Disorders) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 36: Global: Peptide Therapeutics (Cancer) Market: Sales Value (in Million USD), 2019 & 2024
Figure 37: Global: Peptide Therapeutics (Cancer) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 38: Global: Peptide Therapeutics (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
Figure 39: Global: Peptide Therapeutics (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 40: North America: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 41: North America: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 42: United States: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 43: United States: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 44: Canada: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 45: Canada: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 46: Asia-Pacific: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 47: Asia-Pacific: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 48: China: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 49: China: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 50: Japan: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 51: Japan: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 52: India: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 53: India: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 54: South Korea: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 55: South Korea: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 56: Australia: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 57: Australia: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 58: Indonesia: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 59: Indonesia: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 60: Others: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 61: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 62: Europe: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 63: Europe: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 64: Germany: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 65: Germany: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 66: France: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 67: France: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 68: United Kingdom: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 69: United Kingdom: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 70: Italy: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 71: Italy: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 72: Spain: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 73: Spain: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 74: Russia: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 75: Russia: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 76: Others: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 77: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 78: Latin America: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 79: Latin America: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 80: Brazil: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 81: Brazil: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 82: Mexico: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 83: Mexico: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 84: Others: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 85: Others: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 86: Middle East and Africa: Peptide Therapeutics Market: Sales Value (in Million USD), 2019 & 2024
Figure 87: Middle East and Africa: Peptide Therapeutics Market: Breakup by Country (in %), 2024
Figure 88: Middle East and Africa: Peptide Therapeutics Market Forecast: Sales Value (in Million USD), 2025-2033
Figure 89: Global: Peptide Therapeutics Industry: SWOT Analysis
Figure 90: Global: Peptide Therapeutics Industry: Value Chain Analysis
Figure 91: Global: Peptide Therapeutics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Peptide Therapeutics Market: Key Industry Highlights, 2024 and 2033
Table 2: Global: Peptide Therapeutics Market Forecast: Breakup by Type (in Million USD), 2025-2033
Table 3: Global: Peptide Therapeutics Market Forecast: Breakup by Type of Manufacturer (in Million USD), 2025-2033
Table 4: Global: Peptide Therapeutics Market Forecast: Breakup by Synthesis Technology (in Million USD), 2025-2033
Table 5: Global: Peptide Therapeutics Market Forecast: Breakup by Routes of Administration (in Million USD), 2025-2033
Table 6: Global: Peptide Therapeutics Market Forecast: Breakup by Application (in Million USD), 2025-2033
Table 7: Global: Peptide Therapeutics Market Forecast: Breakup by Region (in Million USD), 2025-2033
Table 8: Global: Peptide Therapeutics Market: Competitive Structure
Table 9: Global: Peptide Therapeutics Market: Key Players

Peptide Therapeutics Market Report by Type (Innovative, Generic), Type of Manufacturer (Outsourced, In-House), Synthesis Technology (Solid Phase Peptide Synthesis, Liquid Phase Peptide Synthesis, Hybrid Technology), Routes of Administration (Parenteral, Oral, and Others), Application (Gastrointestinal Disorders, Neurological Disorders, Metabolic Disorders, Cancer, and Others), and Region 2025-2033
Purchase Options New Year Sale
Benefits of Customization
  • Personalize this research
  • Triangulate with your data
  • Get data as per your format and definition
  • Gain a deeper dive into a specific application, geography, customer, or competitor
  • Any level of personalization

Get in Touch With Us

UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-714-6104

Email: sales@imarcgroup.com

Client Testimonials